ESC Highlights 2020
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
RECORDING OF LIVE EVENT: September 28, 2020
The program was developed by the Canadian Collaborative Research Network. We are pleased to make the recording of this live session available to you through MD-Online. Please select the session below to participate. The PROGRAM SLIDES are available from the CCRN website - visit here.
Thank you to our sponsors who supported this program through unrestricted educational funding.
Overview & Objectives
This program will cover the key clinical trial findings and their implications from ESC 2020.
Following participation in this program, participants will be able to:
• Identify the clinical implications of the new data presented at ESC 2020
• Examine where the data presented may impact clinical practice guidelines
• Apply the latest evidence-based strategies in clinical practice
|LoDoCo2 (Inflammation)||Narendra Singh|
|EXPLORER-HCM (Hypertrophic cardiomyopathy)||Narendra Singh|
|EVAPORATE (Atherosclerosis)||Matt Budoff|
|EMPEROR-Reduced (Heart failure)||Milan Gupta|
|DAPA-CKD (Kidney disease)||Milan Gupta|
|BRACE CORONA (ACEi/ARB in COVID infection)||Narendra Singh|
|EXPLORER-HCM (Hypertrophic cardiomyopathy)|
|EMPEROR-Reduced (Heart failure)|
|DAPA-CKD (Kidney disease)|
|BRACE CORONA (ACEi/ARB in COVID infection)|
This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from: